RedHill Biopharma (RDHL) Stock Price
$6.06 0%
to add to portfolio
AI Score
-
Alternative
2 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on RedHill Biopharma, AI stock picks, stock alerts and much more.
RDHL AI Stock Analysis
AI stock analysis for RDHL is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like RedHill Biopharma (RDHL) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
RedHill Biopharma (RDHL) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of RedHill Biopharma (RDHL), currently trading at $6.06, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About RDHL
-
RedHill Biopharma Ltd.
-
Symbol
RDHL
-
Market
NASDAQ
-
Industry
Drug Manufacturers - Specialty & Generic
-
Market Cap
7.7M
Similar Stocks
 |
TherapeuticsMD TXMD |
$1.08 0.9% |
3 |
 |
Tilray TLRY |
$1.04 4.6% |
3 |
 |
Canopy Growth CGC |
$2.03 3.8% |
3 |
 |
Aurora Cannabis ACB |
$3.7 1.3% |
3 |
 |
Sundial Growers SNDL |
$1.73 1.1% |
4 |
RDHL Alternative Data
Web Traffic
RedHill Biopharma receives an estimated 2971 monthly visitors to redhillbio.com.
-
Web Traffic
2971
-
Change from Previous Month
18.8%
-
3 Month Change
10.2%
-
YoY Change
10.2%
News Mentions
RedHill Biopharma was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
RedHill Biopharma has 1,367 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.
-
Twitter Followers
1367
-
Daily Change
0.1%
-
1 Month Change
0.2%
-
3 Month Change
12%
-
YoY Change
12%
LinkedIn Followers
6,703 are following RedHill Biopharma on LinkedIn, up by 0.9% over the last month.
-
LinkedIn Followers
6703
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
2.3%
Job Postings
RedHill Biopharma currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, RedHill Biopharma has 53 employees, down by -3.6% over the last month.
-
LinkedIn Employees
53
-
Daily Change
0%
-
1 Month Change
3.6%
-
3 Month Change
8.6%
-
YoY Change
8.6%
Business Outlook
-
Business Outlook
38
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
RDHL Financials
RDHL Key Metrics
-
Total Revenue
$1.8M
-
Net Income
$761K
-
Earnings per Share
$0.19
-
Free cash flow
-$10.6M
-
EBITDA
$2.7M
-
EBITDA Ratio
1.4961
-
Total Assets
$35M
RDHL 2-year Revenue & Income
RDHL 2-year Free Cash Flow
RDHL Technicals
RDHL SMA
RDHL RSI
FAQ
What's the current price of RedHill Biopharma (RDHL) Stock?
The price of an RedHill Biopharma (RDHL) share is $6.06.
What's the market cap of RedHill Biopharma?
The current market cap of RedHill Biopharma is 7.7M.
Should I buy or sell RDHL?
RedHill Biopharma exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is RedHill Biopharma a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in RedHill Biopharma stock. There are several bearish signals and market challenges that could negatively impact RedHill Biopharma's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy RedHill Biopharma (RDHL) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy RedHill Biopharma stock right now, as the outlook appears bearish.
What are some stocks similar to RedHill Biopharma (RDHL) that investors often compare it to?
RedHill Biopharma (RDHL) is often compared to similar stocks such as TherapeuticsMD, Tilray, Canopy Growth, Aurora Cannabis and Sundial Growers.
What is the forecast for RedHill Biopharma's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast RedHill Biopharma's stock price to be around $5.54 in 2026. Starting from the current price of $6.06, this represents a 8.6% change in price, indicating a bearish outlook for the stock.
How to buy RedHill Biopharma (RDHL) Stock?
RedHill Biopharma stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy RedHill Biopharma shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.